Neonatal herpes virus infection and extracorporeal life support
- PMID: 20101196
- PMCID: PMC3049115
- DOI: 10.1097/PCC.0b013e3181ce71e2
Neonatal herpes virus infection and extracorporeal life support
Abstract
Objectives: To investigate outcomes among neonates with herpes virus infection reported to the Extracorporeal Life Support Organization (ELSO) Registry and analyze factors associated with death before hospital discharge with this virus. Currently, scant data exist regarding extracorporeal membrane oxygenation support in neonates with herpes virus infection.
Design: Retrospective analysis of ELSO Registry data set from 1985 to 2005.
Setting: A total of 114 extracorporeal membrane oxygenation centers contributing data to the ELSO Registry.
Patients: Patients, 0 to 31 days of age, with herpes simplex virus infection supported with extracorporeal membrane oxygenation and reported to the ELSO Registry.
Interventions: None.
Measurements and main results: Clinical characteristics, outcomes, and factors associated with death before hospital discharge were investigated for patients in the virus group. Kaplan-Meier estimates of survival to hospital discharge according to virus type were investigated. Newborns with herpes simplex virus infection requiring extracorporeal membrane oxygenation support demonstrated much lower hospital survival rates (25%). Clinical presentation with septicemia/shock was significantly associated with mortality for the herpes simplex virus group on multivariate analysis. There was no difference in herpes simplex virus mortality when comparing two eras (> or =2000 vs. <2000).
Conclusions: In this cohort of neonatal patients with overwhelming infections due to herpes simplex virus who were supported with extracorporeal membrane oxygenation, survival was dismal. Patients with disseminated herpes simplex virus infection presenting with septicemia/shock are unlikely to survive, even with aggressive extracorporeal support.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures
Comment in
-
Neonatal herpes virus infection: duration of extracorporeal support and the dose of acyclovir.Pediatr Crit Care Med. 2011 Sep;12(5):605; author reply 605-6. doi: 10.1097/PCC.0b013e3182191780. Pediatr Crit Care Med. 2011. PMID: 21897168 No abstract available.
References
-
- Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991;324(7):450–454. - PubMed
-
- Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis. 2005 Oct;16(4):271–281. - PubMed
-
- Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis. 1999;180(1):199–202. - PubMed
-
- Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223–229. - PubMed
-
- Meyer TA, Warner BW. Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. J Pediatr Surg. 1997;32:232–236. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources